Optimi Health Corp. (OPTH)

Optimi Health Corp. is a Canadian pharmaceutical manufacturer based in British Columbia that produces psychedelic drug substances. It holds licenses from Health Canada to produce and supply controlled substances such as psilocybin and MDMA.

The company manufactures these compounds under pharmaceutical-grade standards for use in clinical trials, research and legally permitted access programs, including supply to medical practitioners and research partners. It also works on natural psilocybin extracted from cultivated mushrooms and on formulations of its active ingredients.

Optimi's common shares trade on the Nasdaq under the ticker OPTH.